Skip to main content

Table 2 Baseline prevalence rate of CVD in different stages of CKD in C-STRIDE Study (Nov 2011–Mar 2016)

From: Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE)

Variable

 

eGFR (ml/min/1.73 m2)

P for trend

Total

>60

45–60

30–45

15–30

(n = 3168)

(n = 975)

(n = 497)

(n = 769)

(n = 927)

MI

64 (20.58)

6 (0.62)

9 (1.81)

22 (2.86)

27 (2.91)

0.001

CHF

28 (9.00)

3 (0.31)

5 (1.01)

9 (1.17)

11 (1.19)

0.14

Cerebrovascular disease

215 (69.13)

22 (2.26)

44 (8.85)

58 (7.54)

91 (9.82)

<0.001

PAD

50 (10.08)

3 (0.31)

8 (1.61)

13 (1.69)

26 (2.81)

<0.001

Total CVD

311 (9.82)

31 (3.18)

59 (11.87)

86 (11.18)

135 (14.56)

 
  1. Categorical data are presented as numbers (n) of patients and percentages. MI myocardial infarction, CHF congestive heart failure, PAD peripheral arterial disease